Intravenous immunoglobulin: prospects in patients with autoimmune rheumatic diseases
The published data on efficiency of intravenous immunoglobulin (IVIG) in patients with autoimmune rheumatic diseases (RD) are analyzed. IVIG is the drug of choice in patients with Kawasaki disease, idiopathic thrombocytopenic purpura, dermatomyositis, etc. It is reasonable to use IVIG in RD patients...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2014-03-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/510 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The published data on efficiency of intravenous immunoglobulin (IVIG) in patients with autoimmune rheumatic diseases (RD) are analyzed. IVIG is the drug of choice in patients with Kawasaki disease, idiopathic thrombocytopenic purpura, dermatomyositis, etc. It is reasonable to use IVIG in RD patients with immune deficiency, infectious complications, ineffectiveness of glucocorticoid and cytostatic treatment in patients with developing autoimmune cytopenia, central nervous system dysfunction, and vasculitis. In patients with antiphospholipid syndrome, IVIG can be effective in case of the risk of miscarriage and ineffective anticoagulant therapy. |
---|---|
ISSN: | 1996-7012 2310-158X |